Stoke Therapeutics

US · STOK #2942 by market cap Listed 2019

24.29 -0.08 -0.33%

Live - 5344 symbols - heartbeat 51s ago · 2026-10-08 07:31

Pre-market 23.50 -3.25%

After-hours 24.29 0.00%

Market cap: 1.57B
P/E (TTM): -7.25
P/B: 4.54
EPS: -0.12
Div yield: 0.00%
52W pos: 20%

Reader sentiment Are you bullish or bearish on STOK?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing

The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
Total institutional ownership fell 7.8 percentage points.

Institutional ownership

Held by institutions: 120.73% -7.76pp
Institutions: 240 -1
As of: 2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund68.99%

Hedge Fund34.35%

Public Company11.62%

VC/PE Fund4.21%

Individual/Insider3.71%

Private Company0.78%

Government Pension Fund0.39%

Sovereign Wealth Fund0.26%

Top holders as of 2026-06-30

BlackRock 9.11% · 5.88M sh

RTW Investments, LP 8.72% · 5.62M sh

FMR 8.23% · 5.31M sh

T. Rowe Price Group, Inc. 7.87% · 5.08M sh

Lynx1 Capital Management LP 6.26% · 4.04M sh

Redmile Group, LLC 6.12% · 3.95M sh

BVF Partners L.P. 5.59% · 3.61M sh

Wellington Management Group 5.45% · 3.52M sh

Morgan Stanley 5.31% · 3.43M sh

Baker Bros. Advisors LP 5.17% · 3.34M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 25 buys · 25 sells

Name	Role	Stake
Seth Harrison	Independent Chairperson	2.91%
Adrian Krainer	Co-Founder & Independent Director	0.44%
Edward Kaye	Chief Executive Officer	0.19%
Arthur Tzianabos	Independent Director	0.05%
Arthur Levin	Independent Director	0.03%
Jonathan Allan	Corporate Secretary & General Counsel	0.03%
Barry Ticho	Chief Medical Officer	0.03%
Jason Hoitt	Chief Commercial Officer	0.02%
Thomas Edward Leggett	Chief Financial Officer	0.02%
Ian Smith	Director	--

Insider transactions most recent Form 4 filings

Date	Name	Role	Type	Shares	Price
2026-10-01	Jonathan Allan	Corporate Secretary & General Counsel	Automatic Disposition	-627	$26.33
2026-09-30	Barry Ticho	Chief Medical Officer	Automatic Disposition	-1,051	$26.16
2026-09-22	Alexander Cumbo	Director	Other Derivative Acquisition	+39,674	$26.11
2026-08-31	Barry Ticho	Chief Medical Officer	Automatic Disposition	-5,545	$30.51–31.06
2026-08-17	Edward Kaye	Chief Executive Officer	Derivative Exercise and Sale	-12,567	$32.01–32.47
2026-08-17	Barry Ticho	Chief Medical Officer	Derivative Exercise and Sale	-4,767	$32.01–32.47
2026-08-17	Jonathan Allan	Corporate Secretary & General Counsel	Derivative Exercise and Sale	-2,861	$32.01–32.47
2026-08-13	Edward Kaye	Chief Executive Officer	Derivative Exercise and Retained	+13,683	--
2026-08-13	Barry Ticho	Chief Medical Officer	Derivative Exercise and Retained	+5,233	--
2026-08-13	Jonathan Allan	Corporate Secretary & General Counsel	Derivative Exercise and Retained	+3,139	--
2026-08-02	Barry Ticho	Chief Medical Officer	Automatic Disposition	-7,176	$28.95–29.45
2026-07-15	Seth Harrison	Independent Chairperson	Other Derivative Acquisition	+151,595	$10.90–40.37
2026-07-15	Seth Harrison	Independent Chairperson	Other Derivative Disposition	-151,595	$10.90–40.37
2026-07-14	Thomas McCauley	Chief Scientific Officer	Other Derivative Acquisition	+225,000	$29.91
2026-06-30	Barry Ticho	Chief Medical Officer	Automatic Disposition	-7,228	$32.62–33.27
2026-06-15	Jonathan Allan	Corporate Secretary & General Counsel	Automatic Disposition	-1,457	$29.95
2026-06-02	Seth Harrison	Independent Chairperson	Other Derivative Acquisition	+17,786	$29.46
2026-06-02	Arthur Levin	Independent Director	Other Derivative Acquisition	+17,786	$29.46
2026-06-02	Julie Smith	Independent Director	Other Derivative Acquisition	+17,786	$29.46
2026-06-02	Jennifer Burstein	Independent Director	Other Derivative Acquisition	+17,786	$29.46

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 07:31:22 · For reference only, not investment advice and not tailored to your situation.